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In Plasmodium falciparum, the causative agent of human
malaria, the catalytic subunit gene of cAMP-dependent
protein kinase (Pfpka-c ) exists as a single copy.
Interestingly, its expression appears developmentally
regulated, being at higher levels in the pathogenic
asexual stages than in the sexual forms of parasite that
are responsible for transmission to the mosquito vector.
Within asexual parasites, PfPKA activity can be readily
detected in schizonts. Similar to endogenous PKA
activity of noninfected red blood cells, the parasite
enzyme can be stimulated by cAMP and inhibited by
protein kinase inhibitor. Importantly, ex vivo treatment of
infected erythrocytes with the classical PKA-C inhibitor
H89 leads to a block in parasite growth. This suggests that
the PKA activities of infected red blood cells are essential
for parasite multiplication. Finally, structural considerations
suggest that drugs targeting the parasite, rather than the
erythrocyte enzyme, might be developed that could help in
the fight against malaria.
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The emergence and dissemination of drug-resistant malaria
parasites represents one of the most important public health
problems in many parts of the world today. New
antimalarials are urgently required, whose rational design
and development requires the identification of potential
therapeutic targets. This in turns rests on a better
understanding of the molecular mechanisms controlling
the progression of the complex life cycle of malaria
parasites, especially Plasmodium falciparum, the species
responsible for the lethal form of the disease. All
Plasmodium species are intracellular parasites during
infection of their vertebrate hosts. Sporozoites inoculated
into a host during a bite by an infected Anopheles mosquito
soon invade hepatocytes, within which intense asexual
division takes place (exoerythrocytic schizogony), yielding
up to 40 000 merozoites in the case of P. falciparum (http://
www.malaria.org). Upon schizont rupture, these merozoites
invade red blood cells, where additional rounds of asexual
replication occur (erythrocytic schizogony, the phase
responsible for the pathogenesis of the disease). Some
merozoites, instead of undergoing a further asexual cycle,
arrest their cell cycle and differentiate into male or female
gametocytes. Unlike asexual forms, these sexual forms are
infective to the Anopheles vector.
cAMP is involved in the regulation of development of
several microorganisms, and cAMP-dependent pathways
exist in most eukaryotic cells. For example, in the slime
mold Dictyostelium discoideum, cAMP acts as a signal for
the aggregation and differentiation of cells into a multi-
cellular organism (reviewed in [1]). In most instances,
cAMP exerts its action by binding to the regulatory subunit
complexed to the catalytic subunit in an inactive
holoenzyme of the protein kinase A (PKA or cAMP-
dependent protein kinase), thereby releasing the active
catalytic subunit (PKA-C), whose substrates can include
other protein kinases and transcription factors. PKA activity
is also regulated through binding of its natural inhibitor,
called PKI. The crystal structure of the catalytic subunit of
mouse PKA-C has been resolved and this, combined with
mutational analysis, showed that PKI competes with the
regulatory subunit for binding to the catalytic subunit [2,3].
Several previous reports suggest a role for cAMP (without
directly implicating PKA) in P. falciparum asexual stage
development and erythrocyte invasion [4,5]. In addition,
specific levels of cAMP appear to be important for the
induction of gametocytogenesis (the process of gametocyte
induction). Treatment of P. falciparum cultures with cAMP
agonists, or with phosphodiesterase inhibitors such as caffeine
and 8-bromo-cAMP, result in an increase of gametocyte
induction [6–8]. Moreover, adenylate cyclase activity and
cAMP levels have been correlated with the parasite’s ability
to produce gametocytes [9,10]. A cAMP-dependent histone
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II-A kinase activity has been detected, and a putative
regulatory subunit of 54 kDa observed, in asexual forms of
P. falciparum [11]. Even though the catalytic subunit of
P. falciparum (PfPKA-C) has not been identified, the pka-c
gene from the rodent malaria parasite Plasmodium yoelii has
been cloned [12].
Given the urgent need for new therapeutic drugs against
human malaria, we decided to undertake a study of the
cAMP-dependent protein kinase from P. falciparum, as both
natural and chemical inhibitors of this well characterized
enzyme exist. We show that the human malaria parasite has
a single pka-c gene, whose expression is down-regulated in
gametocytes and gametes. The asexual stage specific kinase
activity is associated with schizonts and, like the
endogenous red blood cell PKA activity, it is sensitive to
cAMP and inhibited by PKI and H89. Inhibition studies
suggest an essential role for PKA in the intraerythrocytic
growth of the parasite. Structural considerations suggest that
it might be possible to specifically inhibit the parasite, rather
than the erythrocyte enzyme, and such drugs would be
viable as new antimalarials.
M A T E R I A L S A N D M E T H O D S
Parasite culture and isolation of gametocytes and
gametes
P. falciparum clone 3D7 parasites were used throughout the
study and gametocytes were isolated from in vitro culture as
described previously [13]. Mature gametocytes were
induced in M199 media (pH 8) to form extracellular
gametes/zygotes. For the PKA inhibition studies, two
reference P. falciparum clones were used, D6 and W2.
which are chloroquine sensitive and chloroquine resistant,
respectively [14].
Isolation of the pka-c gene from P. falciparum
Two independent strategies were employed to isolate the
Pfpka-c gene. A systematic screen of the P. falciparum ESTs
collection was made for clones displaying homology to
PKA-C and an asexual-stage clone (0648c3) was detected
using the information at http://parasite.vetmed.ufl.edu/falc.
htm. In parallel, degenerate oligonucleotide primers were
synthesized and used to amplify Pfpka-c gene from
P. falciparum cDNA using the following conditions: 94 8C
for 1 min, 42 8C for 1 min, and 72 8C for 2 min, for 35 cycles
in a thermocycler (PerkinElmer–Cetus). Forward [GG(A/
T)AC(A/T)GG(A/T)TC(A/T)TT(T/C)GG] and reverse
[TT(A/T)GCAAA(A/T)CCAAAATC(A/T)GT] primers
were deduced from the conserved PKA motifs GTGSFG
and TDFGFAK, respectively [15]. Both the EST (0648c3)
and the PCR fragment were sequenced to confirm their
identity and then used to screen asexual stage [13] and
sexual stage cDNA libraries [16]. Two independent cDNA
clones were sequenced and deposited in the databases
(GenBank acc. nos AJ224444 and U78291).
Southern and Northern blot analysis
Genomic DNA (4mg) was digested with Eco RI, Pst I,
Eco RV, HindIII, Bgl II and ClaI, separated by agarose gel
electrophoresis and transferred to nylon (Hybond-N,
Amersham). Total RNA (3mg) was isolated from asexual
stages, gametocytes and gametes and loaded onto a 1%
agarose gel. RNA was stained by ethidium bromide and
transferred to Hybond-N (Amersham). Both Southern and
Northern filters were probed with radio-labelled Pfpka-c
DNA, washed and exposed to film. To ensure comparable
loading of total RNA from each developmental stage, the
stained gel was visually examined and the Northern blot was
re-probed with the unrelated Pfpast-1 gene [17].
Generation of anti-PfPKA serum and immunofluorescence
analysis
The polyclonal anti-(PfPKA-C) serum was generated by
immunizing rabbits with peptide corresponding to the
C-terminal sequence VPYKPKYKNIFDSSNFE(304–320)
conjugated to keyhole limpet hemocyanin through a
cysteine at the N-terminus of the peptide (ZYMED
Laboratories, Inc., San Francisco, CA, USA). The
specificity of the serum was verified by immunopreciptaion
of the in vitro translation product of the Pfpka-c gene and its
failure to react with noninfected erythrocytes. Asynchro-
nous blood stage parasites were fixed with acetone prior to
incubation with the rabbit antisera used at a 1 : 100 dilution.
The parasite nuclei were stained with 40,6-diamidino-2-
phenylidole (DAPI) (Sigma) and the slides read with a Leica
DMRB microscope.
In vitro PKA activity assays
Parasites were isolated by centrifugation (15 000 g, 4 8C for
10 min) of infected erythrocytes broken by resuspension in
lysis buffer (10 mM Tris/HCl, pH 7.5, 100 mM NaCl, 5 mM
EDTA, 1% Triton X-100, 50mM Na3VO4, 50 mM NaF,
1 mg:mL21 Pefablock SCTM protease inhibitors (Roche,
Mannheim, Germany). Pelleted parasites were washed/
centrifuged three times in NaCl/Pi at 4 8C (50 mL) and
finally resuspended in 1 mL of lysis buffer (1 mL per 5 108
parasites). Parasites were then broken by freeze-thawing
(four cycles) and lysates were clarified by centrifugation at
40 000 g for 90 min. The supernatant was concentrated five-
fold in UltrafreeTM (Millipore Corp., Bedford, MA, USA).
As a control, noninfected erythrocytes were submitted to the
same purification protocol. The protein content of the
extracts was determined by the Bio-Rad (Bradford) protein
assay. Supernatants were aliquoted and stored at 280 8C for
activity assays. PKA activity was assayed by measuring
32P incorporation into the synthetic peptide LRRASLG
(Kemptide; Sigma) using a modified protocol [18]. A typical
assay was performed in a total volume of 25mL containing
50 mM Mops pH 7.0, 40mg:mL21 BSA, 0, 5 mM MgCl2,
300 mM Kemptide, 300 mM [g-32P]ATP (200 –
500 c.p.m.:pmol21), 30mg:mL21 bestatin and 12.5mg of
proteic extract containing 1.5 107 broken parasites
originating from 3 108 infected erythrocytes or 3 108
noninfected erythrocytes. After 20 min at 30 8C, 32P incor-
poration was measured by spotting 10mL of the reaction
mixture onto P81 phosphocellulose filters (Whatman,
Madstone, UK). The filters were washed three times for
5 min in 1% phosphoric acid, once for 5 min in acetone and
dried before scintillation counting. Specificity of the
reaction was assessed by performing the assay in presence
of 40mM cAMP, or in the presence of 88mM of the PKA
q FEBS 2001 Plasmodium falciparum protein kinase A activity (Eur. J. Biochem. 268) 4843
specific inhibitor peptide PKI5224 [19], or of 80mM of H89.
Under the conditions used, reactions were linear over time
and protein amount or parasite content.
Western blot detection of PfPKA-C and human PKA-C
Purified parasites and identically treated healthy erythro-
cytes were resuspended in denaturating loading buffer at the
purification stage preceding the freeze-thawing step (see
above). Erythrocyte (1  1010) extract and schizont
(8.5 107 parasites) extract were submitted to SDS/PAGE
analysis as described in [20] using the anti-(PfPKA-C)
serum (1 : 200) and an anti-(human PKA-Ca) Ig [PKAa cat
(C-20) from Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA] diluted to 1 : 1000. The latter Ig was directed
against the C-terminal end of the human PKA-Ca subunit
that is not conserved in P. falciparum (see Fig. 1).
Control Western blots were performed to estimate
contamination by human PKA-C of the Plasmodium and
noninfected erythrocytes extracts submitted to PKA activity
testing. A volume of lysate containing 1.5 107 parasites
(originating from 8 108 infected erythrocytes) or 8 108
healthy erythrocytes was loaded onto a 10% SDS-
polyacrylamide gel. After electrophoretic separation,
proteins were transferred onto nitrocellulose and submitted
to Western blot analysis as described above using the anti-
(human PKA-Ca) Ig.
Inhibition of intraerythrocytic parasite growth with the
PKA inhibitor H89
The inhibitor H89 (Sigma) was diluted (100mM, 50mM,
25mM, 10mM, 2.5mM, 1mM and 0.5mM) in RPMI. The
starting parasitemia was between 0.1 and 0.5% in group O1
erythrocytes and the hematocrit was 1.7% in 11.4% human
serum buffered with 25 mM Hepes and 25 mM NaHCO3. A
total of 175mL of this suspension was placed into 96-well
plates (FalconTM), together with 25mL of the different
concentrations of H89, giving a final hematocrit of 1.5% in
10% human serum. The plates were shaken in the presence
Fig. 1. PfPKA-C shares significant homology with PKA-C subunits from other species. Sequence comparison of PfPKA-C with PKA catalytic
subunits from P. yoelii (PyPKA), human a subunit (HsPKA), mouse a subunit (MmPKA) and yeast TPK1 (ScPKA). The CLUSTAL W analysis shows
(using BOXSHADE) identical residues (black) and similar amino acids (grey) conserved between the different kinases with a consensus indicated when
the same residue was found in three or more enzymes. The 15 residues common to most serine/threonine protein kinases are labelled with a dot.
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of radiolabeled-hypoxanthine (40 mCi:mL21 or 1 mCi) for
42 h at 37 8C in a humid incubator gassed with 6% CO2, 10%
O2 and 84% N2. Forty-two hours after addition of
hypoxanthine the plates were frozen at 280 8C and then
quickly thawed, causing hemolysis and release of
radiolabeled nucleoproteins. These were collected (Filter-
mateTM, Packard Instrument Co.) on standard microplate
filters (UnifilterTM GF/B) and when dry, 100mL of
scintillant were added (MicroscintTM) and the radioactivity
counted (c.p.m.:min21) using a Top CountTM (Packard
Instrument Co.) scintillation counter. The results were
submitted to linear regression analysis and the dose of
H89 giving 50% inhibition was calculated from three
independent experiments.
R E S U L T S
Identification of Pfpka-c, a P. falciparum homologue of
the PKA catalytic subunit gene
Using either specific PCR or EST fragments a number of
independent P. falciparum cDNA clones encoding a Pfpka-c
homologue were isolated (see Fig. 1 for the deduced amino-
acid sequence). Pfpka-c is very closely related (88%
identity) to the orthologous gene (Pypka-c, acc. no. D45894)
from P. yoelii [12]. As expected, the 15 signature residues
conserved in serine/threonine protein kinases are present in
the deduced amino-acid sequence of PfPKA-C, as are most
of the residues that are conserved in all PKAs. However,
some crucial residues common to PKA catalytic subunits
have been substituted (some in a nonconservative manner)
in the two plasmodial enzymes, see Fig. 1, and [12].
Pfpka-c is a single copy gene whose expression is
developmentally regulated
Southern and Northen blotting, combined with PCR analysis
on genomic DNA vs. cDNA, indicates that like Pypka-c
[12], Pfpka-c is a multi-intron single copy gene (Fig. 2A,
and data not shown). The two bands shown in the Eco RI
digest (lane 1) are consistent with the presence of an internal
site within the coding sequence. The Pfpka-c gene is
expressed as a 1.6-kb transcript in intraerythrocytic stages
and we note that mRNA levels are lower in gametocytes and
gametes (compare lanes 1 with lanes 2 and 3 of top panel in
Fig. 2B). Clearly, the expression of Pfpka-c is down-
regulated in gametocytes/gametes (compare top and bottom
panels in Fig. 2B).
PfPKA-C activity is highest in intraerythrocytic schizonts
Having demonstrated that P. falciparum asexual stage
parasites accumulate Pfpka-c mRNA, we next examined
the different intraerythrocytic stages for the presence of the
enzyme. To this end, we raised a specific anti-(PfPKA-C)
serum and performed indirect immunofluorescence analysis
of P. falciparum-infected red blood cells (Fig. 3). This
Fig. 3. Antibodies raised to PfPKA-C react preferentially with
multinucleated schizonts. Top shows green immunofluorescence
staining of intraerythrocytic parasites labelled with anti-(PfPKA-C) Ig
and bottom, the nuclei of the same parasites stained blue with DAPI.
The strongly DAPI labelled multinucleated schizonts stain strongest
with the anti-(PfPKA-C) Ig.
Fig. 2. Pfpka-c is a single copy gene expressed strongly in asexual
stages and down-regulated in gametocytes and gametes. (A)
Southern blot of P. falciparum genomic DNA restricted with (1)
Eco RI; (2) Pst I; (3) Eco RV; (4) Hind III; (5) Bgl II (6) Cla I. (B) Total
RNA (middle panel, ethidium bromide stain) corresponding to asexual
stages (1), gametocytes (2) and gametes (3) was hybridized with
Pfpka-c (top panel) and PfPast-1 (bottom panel) as a control.
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showed that the PfPKA-C protein can be detected in all
stages from mononucleated (single small blue dots) rings, to
multinucleated (multiple blue dots) schizonts. The anti-
(PfPKA-C) Ig appears to have the desired specificity, as it
can immunoprecipitate the in vitro translated enzyme (data
not shown) and fails to react with noninfected (non-DAPI
stained) erythrocytes (Fig. 3). Next, we used the anti-
(PfPKA-C) Ig together with an anti-(human PKA-Ca) Ig to
detect both parasite and human PKA-C in schizont extracts
and extracts made from noninfected erythrocytes (Fig. 4).
As in the immunofluorescence studies, anti-(PfPKA-C) Ig
failed to recognize the human enzyme (lane IIA) and it can
be seen that PfPKA-C (lane IIB) migrates more slowly than
the human enzyme detected in noninfected red blood cells
(lane IA). Interestingly, human PKA-C appears significantly
degraded in infected erythrocyte extracts as two bands are
observed (lane IB). The faster migrating species probably
results from N-terminal cleavage of the enzyme, which is
believed to be inactive under physiological conditions
[20,21]. Moreover, the predominant degradation product
cannot be detected in soluble extracts of freeze-thawed
treated parasites (data not shown) and thus, is unlikely to
contribute to PKA-C activity measured in schizont extracts.
Furthermore, the b-isoform of human PKA-C could not be
detected in any red blood cell extract (data not shown) using
a specific antibody [Santa-Cruz Biotech. PKAb cat (C-20)].
We next correlated detection of the PfPKA-C protein by
immunofluorescence and Western blot with the presence of
a PKA activity in cell extracts. To this end, we synchronized
the parasite population and submitted the extracts to a
c-AMP-dependent kinase activity in a Kemptide assay (see
Materials and methods). The results, shown in Fig. 5,
indicate that a cAMP-dependent kinase activity is detectable
in multinucleated schizonts (B) at a higher level than in
noninfected erythrocyte extracts (A). As expected for a
cAMP dependent protein kinase, the activity is inhibited by
PKI and slightly increased by cAMP, which suggests the
presence of an active regulatory subunit (see Discussion).
Moreover, inhibition of the schizont PKA activity in vitro by
the specific inhibitor H89 (Fig. 5, dotted bars) parallels the
effect of H89 observed on infected red blood cells (see
below; Table 1). The inset of Fig. 5 shows that the higher
activity found in schizonts is not due to increased
contamination of the parasite extracts by human PKA-C.
Although readily observed by Western blot in total cell
extracts (Fig. 4), PfPKA-C was difficult to detect in soluble
extracts of schizonts (data not shown). This suggests that
most of the parasite enzyme could be lost during preparation
of extracts for the Kemptide assays, which might explain
why PKA activity of schizonts appears reproducibly to be
only twofold that found in red blood cells.
Treatment of infected erythrocytes with the PKA inhibitor
H89 blocks parasite growth
Having demonstrated that P. falciparum-infected erythro-
cytes have PKA-C activity we then wanted to know if it was
necessary for parasite growth within the red blood cell. We
used the highly specific PKA inhibitor H89, rather than PKI,
as H89 is membrane permeable and can be given to live
cells. At reasonably low doses (IC50 at less than 3mM) we
observed parasite growth arrest ex vivo (Table 1). H89 was
equally effective on chloroquine resistant and choloroquine
sensitive parasites (2.5 vs. 2.9mM).
Structural considerations suggest the possibility of
developing specific PfPKA inhibitors
Much structural analysis has been performed on mouse
PKA-C [3], which displays significant similarity with the
parasite enzyme (see Fig. 1). One can see immediately that
the catalytic centre (including the ATP-binding site) is
strictly conserved, which could suggest that available
protein kinase inhibitors based on nucleotide analogues of
ATP might not be good candidates for specific PfPKA
inhibition. We present in Fig. 6A the 3D structure of mouse
the PKA-C a subunit complexed with the inhibitor PKI
Fig. 4. Western blot detection of PfPKA-C and human PKA-C a in
cell extracts. Non-infected erythrocyte extract (A) and schizont total
cell extract (B), prepared as described in Materials and methods, were
submitted to Western blot analysis using anti-(human PKA-C a) Ig (I)
and anti-(PfPKA-C) Ig (II). Molecular masses of marker proteins are
expressed in kDa.
Fig. 5. Developmentally-regulated PKA activity in cellular extracts
from schizonts. PKA activity, expressed in pmol of ATP per min and
per mg of protein extract, was measured as described in Materials and
methods the in absence (black bars) or presence (white bars) of cAMP,
in presence of cAMP and PKI (slanted bars), and in presence of cAMP
and H89 (dotted bars). Inset: Western blot detection of human PKA-C a
subunit in the extracts submitted to PKA activity testing. Cell extracts
were from noninfected erythrocytes (A), and from schizonts (B). The
standard deviations calculated represent the mean values of five
independent experiments.
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(shown in yellow), where we have colour-coded the residues
conserved (blue) and variant (red) with PfPKA-C. It is
noteworthy that most amino-acid differences between the
protozoan and mammalian enzymes are distributed across
the molecular surface and importantly, certain variants
correspond to amino-acid residues that are in contact with
(or in close proximity to) the PKI inhibitor. These include
Leu82 in mouse PKA (replaced by Gln in PfPKA) that
interacts with a His residue of PKI, and Tyr330 (Val) and
Glu328 (Asp), both of which are located close to one of the
two conserved Arg residues in PKA substrates. In addition,
at the periphery of the PKI-binding cleft, the mouse PKA
loop between positions 235 and 245 includes several amino-
acid residues that are changed in PfPKA (Figs 1 and 6A).
Because we treated infected erythrocytes with H89 we show
it (yellow) complexed with the porcine enzyme in Fig. 6B.
The conserved amino acids are coloured green, the G-loop
as a white ribbon and the C-terminus as a purple ribbon. One
can see that the H89 binding site of the parasite enzyme has
two variant residues (shown red). In spite of these
differences, we have shown that Kemptide, PKI and H89
are PfPKA-C ligands in vitro, but clearly differential-
binding efficiencies for PKA inhibitors could occur between
the mammalian and parasite enzymes in vivo. In this
context, differential susceptibilities of homologous kinases
(yeast CDC28 and starfish cdc2) to the same inhibitor have
been reported [22].
D I S C U S S I O N
We have cloned and characterized the catalytic subunit gene
for the cAMP-dependent kinase of P. falciparum. Following
our original deposition of the PfPKA-C sequence in the
database, a subsequent report has appeared [23]. Interest-
ingly, Pfpka-c gene expression appears to be developmen-
tally regulated, decreasing markedly in sexual stage
parasites (Fig. 2). The predominant Pfpka-c expression in
asexual blood stages described here and by Li and Cox [23]
may in fact be restricted to schizonts, as a recent microarray-
based study of gene expression also detected Pfpka-c
transcripts at this stage [24]. The developmental down-
regulation of Pfpka-c levels in sexual stages may render
regulation of the kinase more sensitive to fluctuations in
cAMP, thereby explaining the effect of this compound on
gametocytogenesis in P. falciparum cultures [6–8]. Alter-
natively, it is possible that the observed effect of cAMP on
gametocytogenesis may result from a signalling event
involving the PKA activity present in the preceding
Fig. 6. Divergent residues between PfPKA and mammalian PKA-Cs. (A) Mouse PKA-C a bound to the PKI inhibitor (yellow). Amino-acid
residues that differ between the mouse and plasmodial enzymes are coloured red, identical residues are coloured blue. The atomic co-ordinates of the
mouse PKA/PKI complex were taken from the RCSB PDB (accession code 1ATP). The figure was made using the program QUANTA (MSI Inc.). (B)
Amino acids from porcine PKA-C a implicated in binding to the H89 inhibitor (yellow) according to Engh et al. [26]. Amino-acid residues that differ
between the porcine and plasmodial enzymes are coloured red, identical residues are coloured green. Part of the G-loop (amino acids 48–57) and of
the C-terminal end (amino acids 312-329) are shown as grey and purple ribbons, respectively. The atomic co-ordinates of the bovine PKA/PKI/H89
complex were taken from the RCSB Protein Data Bank (accession code 1YDT). Molecular modelling of the enzyme complex was carried out on a
Silicon Graphics O2 wok-station using INSIGHT II 98 software (Biosym/MSI).
Table 1. Inhibition (IC50) of intraerythrocytic growth of P. falci-
parum by the PKA inhibitor H89. The inhibition tests were performed
on two P. falciparum reference clones, where D6 is chloroquine
sensitive and W2 is chloroquine resistant. The results are expressed as
the minimal concentration at which 50% inhibition of growth was
observed with H89 and were calculated following linear regression
analysis.
Independent experiment
IC50 (mM)
Clone CQ-S D6a Clone CQ-R W2b
1 1.4 3.2
2 4.6 1.9
3 2.6 2.3
Average concentration 2.9 2.5
a Standard deviation 1.6, standard error 0.9, 95% Confidence interval
1.4–4.4mM. b Standard deviation 0.7, standard error 0.4, 95% Confidence
interval 2.0–3.0mM.
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schizont. This notion is based on the observation that in
P. falciparum cultures commitment to sexual differentiation
occurs during the asexual cycle producing the merozoites
that will develop into gametocytes [25].
Importantly, our ability to ascribe the majority of Pfpka-c
gene expression and enzymatic activity to asexual schizonts
suggests that parasite PKA activity might be necessary for
completion of the asexual cycle, or re-invasion of
erythrocytes. Although the H89 inhibitor studies (Table 1)
support this view, the presence of an endogenous PKA
activity in red blood cells hampers clear interpretation, as it
is possible that intraerythrocytic growth arrest could be due
to a block in erythrocyte, rather than parasite PKA activity.
Clearly, differential inhibition of the two kinases will be
required to delineate between these two possibilities. In this
context, structural comparisons between the parasite and
mouse PKA-C enzymes revealed both distinct areas of
conserved residues, and divergent regions (Fig. 6). One area
of conservation corresponds to the enzymatic reaction
centre and the other covers a region that has been proposed
to interact with the globular domain of the mouse regulatory
subunit PKA-R [2]. A putative regulatory subunit has been
biochemically identified in P. falciparum extracts [10] and a
gene showing significant identity (< 40%) to regulatory
subunit genes from other species is present in the
nonannotated database (http://baggage.stanford.edu/
cgi-misc/PlasmodiumSubmission.cgi). This suggests that
not only the catalytic mechanism, but also the overall mode
of interaction between the catalytic and the regulatory
subunits are conserved across the entire family of PKAs and
are functional in malaria parasites. The ability of cAMP to
stimulate PfPKA activity in the in vitro kinase assays
(Fig. 5) is consistent with this notion.
For the parasite proliferation studies, the chemical
inhibitor H89 was used in preference to the commercially
available PKI inhibitor, because unlike PKI, H89 is
membrane permeable and can be given to live cells.
Moreover, most of the 14 amino acids of the porcine PKA
catalytic subunit implicated in the H89 drug binding [26] are
conserved, with the exception that M120 and Y122 (porcine
numbering) are substituted by L112 and F114 (P. falciparum
numbering) in the parasite enzyme (Fig. 6B). As expected,
given the degree of conservation in the binding site, the PKA
activity detected in schizont extracts was inhibited by H89.
Although at this concentration (3mM) H89 also inhibited
erythrocyte PKA activity in vitro, the presence of two
divergent residues in the binding site suggests that variants
of H89 might be developed that preferentially inhibit the
parasite enzyme. The availability of recombinant active
PfPKA-C should facilitate testing of other inhibitors, where
a parasite-specific compound could eventually lead to a
novel drug for treatment of malaria.
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